Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma

被引：0
作者：
Zhuang, Y. [1 ]
Chen, Y. [1 ]
Du, S. [2 ]
Hu, Y. [1 ]
Zeng, Z. C. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2789
引用
收藏
页码：E360 / E360
页数：1
相关论文
共 50 条
[31]   Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis [J].
Yang, Miaomiao ;
Jiang, Xiongying ;
Liu, Huan ;
Zhang, Qingyu ;
Li, Jing ;
Shao, Li ;
Zhao, Lei .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[32]   Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response [J].
Yang, Fei ;
Xu, Gui-Li ;
Huang, Jin-Tao ;
Yin, Yu ;
Xiang, Wei ;
Zhong, Bin-Yan ;
Li, Wan-Ci ;
Shen, Jian ;
Zhang, Shuai ;
Yang, Jun ;
Sun, Hong Peng ;
Wang, Wan-Sheng ;
Zhu, Xiao-Li .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[33]   The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma [J].
Todeschini, Letizia ;
Cristin, Luca ;
Martinino, Alessandro ;
Mattia, Amelia ;
Agnes, Salvatore ;
Giovinazzo, Francesco .
CURRENT ONCOLOGY, 2023, 30 (06) :5574-5592
[34]   Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma [J].
Zhan-Wang Xiang ;
Lin Sun ;
Guo-Hong Li ;
Rakesh Maharjan ;
Jin-Hua Huang ;
Chuan-Xing Li .
World Journal of Hepatology, 2015, (20) :2309-2314
[35]   Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation [J].
Castroagudín, JF ;
González-Quintela, A ;
Martínez, J ;
Tomé, S ;
Forteza, J ;
Varo, E .
HEPATO-GASTROENTEROLOGY, 2002, 49 (43) :249-251
[36]   Two Rare Metachronous Metastases of Hepatocellular Carcinoma After Liver Transplantation [J].
Shinya, Satoshi ;
Noritomi, Tomoaki ;
Yamauchi, Yasushi ;
Sasaki, Takamistu ;
Hamada, Yoshihiro ;
Yamashita, Yuichi .
INTERNATIONAL SURGERY, 2013, 98 (04) :432-436
[37]   Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma [J].
Xiang, Zhan-Wang ;
Sun, Lin ;
Li, Guo-Hong ;
Maharjan, Rakesh ;
Huang, Jin-Hua ;
Li, Chuan-Xing .
WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (20) :2309-2314
[38]   Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma [J].
Wei, Qiang ;
Xu, Xiao ;
Wang, Chao ;
Zhuang, Runzhou ;
Zhuang, Li ;
Zhou, Lin ;
Xie, Haiyang ;
Wu, Jian ;
Zhang, Min ;
Shen, Yan ;
Wang, Weilin ;
Zheng, Shusen .
GUT AND LIVER, 2016, 10 (04) :604-610
[39]   Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization [J].
Lin, Long-Wang ;
Ke, Kun ;
Yan, Le-Ye ;
Chen, Rong ;
Huang, Jing-Yao .
FRONTIERS IN ONCOLOGY, 2023, 13
[40]   Efficacy and safety of hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in advanced hepatocellular carcinoma: A systematic review and meta-analysis [J].
Li, Zixiong ;
Xu, Yanping ;
Qu, Wenshu ;
Liu, Ping ;
Zhu, Yan ;
Li, Hui ;
Guo, Ying ;
Liu, Xiufeng .
ONCOLOGY LETTERS, 2023, 26 (06)
12345